<DOC>
	<DOCNO>NCT00166842</DOCNO>
	<brief_summary>The purpose study understand pharmacokinetics sirolimus tablet different regimen newly renal transplant patient , effect dosage form conversion concentration sirolimus stable renal transplant patient . So design good tacrolimus cyclosporine/sirolimus/steroid dose regimen Taiwanese .</brief_summary>
	<brief_title>Sirolimus Blood Concentrations Conversion From Oral Solution Tablets</brief_title>
	<detailed_description>Sirolimus tablet available one year launch sirolimus solution . Most patient sirolimus solution use sirolimus tablet instead . The purpose study understand pharmacokinetics sirolimus tablet different regimen newly renal transplant patient , effect dosage form conversion concentration sirolimus stable renal transplant patient . So design good tacrolimus cyclosporine/sirolimus/steroid dose regimen Taiwanese .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>age 18 65 , renal transplant patient pregnancy , tuberculosis , hepatitis B C carrier status , human immunodeficiency virusÔºçpositive status , retransplantation multiorgan transplantation , history rheumatoid arthritis transplantation</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2002</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Cyclosporine</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Kidney Transplantation</keyword>
</DOC>